Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OsteoKing for femoral shaft fracture after intramedullary fixation
ChiCTR1900024738Phase 4Not yet recruiting
- Sponsor
- Beijing Jishuitan Hospital
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of OsteoKing in Femoral diaphyseal fracture (2 arms), sponsored by Beijing Jishuitan Hospital. Primary endpoints: VAS score for pain and Radiographic Union Score. Planned start May 2019; status: not yet recruiting.
02
Drugs
OsteoKing
03
Conditions
Femoral diaphyseal fracture
Beyond the preview
Go deeper on ChiCTR1900024738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900024738.